Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bionano Genomics Inc (BNGO)

Bionano Genomics Inc (BNGO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,291,358
  • Shares Outstanding, K 153,186
  • Annual Sales, $ 10,130 K
  • Annual Income, $ -29,820 K
  • 60-Month Beta 2.91
  • Price/Sales 83.07
  • Price/Cash Flow N/A
  • Price/Book 65.58
Trade BNGO with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.06
  • Number of Estimates 2
  • High Estimate -0.06
  • Low Estimate -0.07
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.01%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.49 +1,611.68%
on 12/16/20
9.50 -11.26%
on 01/15/21
+7.92 (+1,542.63%)
since 12/15/20
3-Month
0.47 +1,678.86%
on 11/06/20
9.50 -11.26%
on 01/15/21
+7.85 (+1,361.01%)
since 10/15/20
52-Week
0.25 +3,272.00%
on 04/02/20
9.50 -11.26%
on 01/15/21
+7.26 (+620.51%)
since 01/15/20

Most Recent Stories

More News
Thinking about buying stock in Obseva SA, DBV Technologies, BlackBerry, Five Prime Therapeutics, or BioNano Genomics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OBSV, DBVT, BB, FPRX, and BNGO.

BNGO : 8.43 (+21.29%)
DBVT : 5.66 (+51.34%)
FPRX : 14.22 (-10.90%)
OBSV : 4.07 (+61.51%)
BB : 9.84 (+8.01%)
Day Four of Bionano's Next-Generation Cytogenomics Symposium: Saphyr Solves Genetic Mysteries, Enables Study of Complex Genetic Diseases, Simplifies Muscular Dystrophy Testing

-- Saphyr can measure large expansions of disease-causing genomic repeats, impossible with other modern techniques, enabling study of a broad range of currently inaccessible genetic diseases

BNGO : 8.43 (+21.29%)
Thinking about buying stock in Sundial Growers, FuelCell Energy, Nokia, BioNano Genomics, or Biolase?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNDL, FCEL, NOK, BNGO, and BIOL.

BNGO : 8.43 (+21.29%)
FCEL : 15.84 (-10.00%)
SNDL : 0.7136 (+3.39%)
BIOL : 0.8330 (-8.87%)
NOK : 4.08 (-0.24%)
Day Three of Bionano's Next-Generation Cytogenomics Symposium: Saphyr Provides Complete Structural Variation Analysis in Solid Tumors, Enables Discovery of Novel Diagnostic Markers and Drug Targets

-- Saphyr outperforms Oncoscan array for structural variation and copy number variation detection in solid tumors

BNGO : 8.43 (+21.29%)
Bionano Genomics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement

Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that it has received a letter from the Nasdaq Listing Qualifications staff notifying the Company that it has regained compliance with Nasdaq's minimum...

BNGO : 8.43 (+21.29%)
Day Two of Bionano's Next-Generation Cytogenomics Symposium: Saphyr Outperforms Standard Cytogenetics in Heme Malignancies, is Less Expensive, Provides Actionable Information Faster, in Single Assay

-- Saphyr identifies additional variants missed by traditional methods that have prognostic and therapeutic value, with a faster turn-around time and lower cost

BNGO : 8.43 (+21.29%)
Bionano Genomics Announces Closing of $101.8 Million Underwritten Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

BIONANO GENOMICS, INC. (Nasdaq: BNGO), announced today the closing of its previously announced underwritten public offering of 33,368,851 shares of its common stock, including 4,352,458 shares sold pursuant...

BNGO : 8.43 (+21.29%)
Thinking about buying stock in Biolase, Transocean, BP, AMC Entertainment, or BioNano Genomics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BIOL, RIG, BP, AMC, and BNGO.

BNGO : 8.43 (+21.29%)
BIOL : 0.8330 (-8.87%)
AMC : 2.33 (+6.88%)
BP : 24.26 (-4.75%)
RIG : 3.28 (-6.02%)
Day One of Bionano's Next-Generation Cytogenomics Symposium: Customer Progress in Applications Development in Prenatal Testing, Validation Against Traditional Cytogenetics and Resolution for Undiagnosed Patients

-- 100% concordance with standard cytogenetic and molecular methods in genetic diseases reported

BNGO : 8.43 (+21.29%)
Thinking about buying stock in Nio, Zomedica, Transenterix, Aileron Therapeutics, or BioNano Genomics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NIO, ZOM, TRXC, ALRN, and BNGO.

TRXC : 2.07 (+4.02%)
ZOM : 0.9751 (-3.46%)
ALRN : 1.8400 (-5.64%)
BNGO : 8.43 (+21.29%)
NIO : 56.27 (-7.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

BioNano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The Company offers proprietary nanochannel chips, automated imaging instrument, integrated primary and secondary software, and application specific reagents. BioNano Genomics, Inc. is based in San...

See More

Key Turning Points

3rd Resistance Point 11.45
2nd Resistance Point 10.48
1st Resistance Point 9.45
Last Price 8.43
1st Support Level 7.45
2nd Support Level 6.48
3rd Support Level 5.45

See More

52-Week High 9.50
Last Price 8.43
Fibonacci 61.8% 5.97
Fibonacci 50% 4.88
Fibonacci 38.2% 3.78
52-Week Low 0.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar